US Drug Recall Register

FDA Drug Recalls

11,815 recalls · Class II, newest first

Risk Class IClass IIClass III
Status OngoingCompletedTerminated
Year 2026202520242023
Class II · Moderate risk Terminated

Methadone

Reason Lack of sterility assurance

Sentara Infusion Services D-0304-2023
Class II · Moderate risk Terminated

Meropenem

Reason Lack of sterility assurance

Sentara Infusion Services D-0303-2023
Class II · Moderate risk Terminated

Levaquin 750MG IN D5W 150ML

Reason Lack of sterility assurance

Sentara Infusion Services D-0301-2023
Class II · Moderate risk Terminated

Intralipid 18gm

Reason Lack of sterility assurance

Sentara Infusion Services D-0298-2023
Class II · Moderate risk Terminated

Hydromorphone

Reason Lack of sterility assurance

Sentara Infusion Services NDC 00703-0018-01 D-0296-2023
Class II · Moderate risk Terminated

Ganciclovir

Reason Lack of sterility assurance

Sentara Infusion Services D-0294-2023
Class II · Moderate risk Terminated

Fluconazole 200mg Ns 100ml

Reason Lack of sterility assurance

Sentara Infusion Services D-0293-2023
Class II · Moderate risk Terminated

Ethanol 70% 0.5ml Syringe

Reason Lack of sterility assurance

Sentara Infusion Services D-0292-2023
Class II · Moderate risk Terminated

Ertapenem

Reason Lack of sterility assurance

Sentara Infusion Services D-0291-2023
Class II · Moderate risk Terminated

Dobutamine

Reason Lack of sterility assurance

Sentara Infusion Services D-0290-2023
Class II · Moderate risk Terminated

Dextrose 10% 720ML

Reason Lack of sterility assurance

Sentara Infusion Services D-0288-2023
Class II · Moderate risk Terminated

Daptomycin

Reason Lack of sterility assurance

Sentara Infusion Services D-0287-2023
Class II · Moderate risk Terminated

Daptomycin

Reason Lack of sterility assurance

Sentara Infusion Services D-0286-2023
Class II · Moderate risk Terminated

D5 Ns 2300ml

Reason Lack of sterility assurance

Sentara Infusion Services D-0284-2023
Class II · Moderate risk Terminated

Ceftriaxone

Reason Lack of sterility assurance

Sentara Infusion Services D-0283-2023
Class II · Moderate risk Terminated

Ceftriaxone

Reason Lack of sterility assurance

Sentara Infusion Services D-0282-2023
Class II · Moderate risk Terminated

Cefoxitin

Reason Lack of sterility assurance

Sentara Infusion Services D-0281-2023